A medical system includes a shaft having a proximal end and a distal end, a balloon attached to the distal end of the shaft, the balloon movable between an expanded state and a deflated state where a maximum diameter of the balloon is greater in the expanded state than in the deflated state, and an electrode is attached to the shaft where a portion of the balloon includes a plurality of apertures fluidly connecting an interior of the balloon to an exterior of the balloon.

Disclosed is a device for providing resuscitation or suspended state through redistribution of cardiac output to increase supply to the brain and heart for a patient. The device includes an electrically controllable redistribution component attachable to the patient to provide redistribution of the cardiac output to increase supply to the brain and heart. The redistribution component, following a predefined reaction pattern based on an electrical signal, and computer means configured to: receive a patient data which identifies physiological and/or anatomical characteristics of the patent; and provide the electrical signal for the redistribution component based on the patient data or a standard response. The device may provide mechanisms to protect the aorta and the remaining anatomy of the patient from inadvertent damage caused by the disclosed device in any usage scenario of either correct intended usage or unintended usage. Also disclosed is a method for providing resuscitation or suspended state.

Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.

Systems, apparatuses, and methods for treating a patent foramen ovale (PFO) of a patient. A system may include a catheter configured to extend within at least a portion of the patients heart. One or more stabilizer balloons may be coupled to the catheter and configured to be positioned within a tunnel of the patent foramen ovale and inflated to apply a force to at least one of a septum primum or a septum secundum of the patients heart. An injection device may be configured to inject material into at least one of the septum primum or the septum secundum to cause swelling of the injected septum primum or the injected septum secundum in a direction towards the opposing septum primum or the opposing septum secundum.

The present invention relates to a medical treatment device for stimulating neurons of a patient. The device comprises a first non-invasive stimulating device for generating at least two different first stimuli to a patient's body, a second non-invasive stimulating device for generating at least two different second stimuli to the patient's body, and a control unit for selectively and intermittently actuating the stimulating devices. In a first operating mode, the control unit is configured to actuate the first stimulating device in a sequence of successive actuating periods such that a number n of first stimuli to be generated simultaneously during the actuating periods is variedly determined across the sequence and to actuate the second stimulating device so as to generate the second stimuli to be paired to the generation of at least a part of the first stimuli. In a second operating mode, the control unit is configured to actuate the second stimulating device so as to generate the second stimuli to be de-coupled from the generation of at least a part of the first stimuli.

An apparatus, comprising, a cochlear implant electrode array, and an implantable drug reservoir, wherein the apparatus is configured such that the drug reservoir is in fluid communication with the electrode array, and the drug reservoir is at least substantially located in a middle ear space when the cochlear implant electrode array is fully implanted in a recipient.

A method, apparatus and computer system product for improving cardiac output from the heart is presented. A balloon is placed within a chamber of a heart wherein the balloon encloses a mechanical expansion device and air. During a first time epoch in which the heart chamber is volumetrically contracting (during emptying), a mechanical expansion device causes the balloon to increase in size, which improves ejection fraction. During a second time epoch in which the heart chamber is volumetrically expanding (during filling), the mechanical expansion device causes the balloon to decrease in size, which improves filling.

An electro-magnetic induction device for activating a target tissue in a body via its muscular or neural system includes an electro-magnetic field generator with a coil design configured to generate an electro-magnetic field, a mounting arrangement holding the coil design at the body, a sensor member configured to detect an activation of a target tissue, an electro-magnetic field adjustment mechanism configured to automatically adjust the position and a field strength of the electro-magnetic field, and a calibration unit in communication with the sensor member and the electro-magnetic field adjustment mechanism. The calibration unit is configured to control the electro-magnetic field adjustment mechanism to automatically vary the position and the field strength of the electro-magnetic field, to receive an activation feedback signal from the sensor, and to control the electro-magnetic field adjustment mechanism to automatically stop variation of the position of the electro-magnetic field generated by the coil design.

The invention generally relates to a continuous anesthesia nerve conduction apparatus and method thereof, and more particularly to a method and system for use in administering a continuous flow or intermittent bolus of anesthetic agent to facilitate a continuous or prolonged nerve block. In one embodiment, the apparatus includes a sheath having a proximal end, a distal end and at least one lumen extending from the proximal end to the distal end. The sheath also includes an embedded conductive element for transmitting an electrical signal from a proximal portion of the sheath to a distal portion of the sheath. A cannula is arranged in the at least one lumen of the sheath and has a distal end protruding from a distal portion of the sheath. The cannula is electrically coupled to at least a portion of the embedded conductive element and is configured to provide nerve stimulation.

A medical system includes a manual patient ventilation unit defining an airflow path arranged so that when the unit is applied to a patient the airflow path is in fluid communication with the patient's airway. The patient ventilation unit includes a ventilation bag configured to enable manual ventilation of the patient by a rescuer, an airflow sensor in the airflow path positioned to sense the presence of ventilation airflow and measure a gas flow rate in the airflow path, and a pressure sensor in the airflow path positioned to sense gas pressure in the airflow path. The system also includes a processor arranged to receive data generated by the airflow sensor and the pressure sensor and determine one or more ventilation quality parameters based at least in part on a gas flow volume calculated based on the sensed gas flow rate and gas pressures.